Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

F/TAF Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis (TAF4TRANS)

NCT04616963 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04616963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
F/TAF Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis (TAF4TRANS)
Lead sponsor
University of California, San Diego
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 24, 2019
Completion date
January 31, 2024
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hormone therapy